Inspire Medical Q4 revenue $192.5M (+40%), first net income quarter $14.8M

Inspire Medical Systems, Inc.

2023-FY EPS reported -$0.72 revenue$624,799,000

Q4 revenue $192.5M (+40% YoY); full year $624.8M (+53%). U.S. revenue $189.4M (+41%).
Q4 net income $14.8M (diluted EPS $0.49) vs $3.2M ($0.10) a year ago; FY net loss improved 53% to $21.2M.
Gross margin 85.4% in Q4 vs 83.9% a year ago; FY 2024 guidance 83%-85%.
Reaffirms FY 2024 revenue guidance of $775M-$785M (24-26% growth).
Added 78 new U.S. implanting centers in Q4 (total 1,180) and 13 sales territories (total 287).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Inspire Medical Systems, Inc. reported the quarter and year ended December 31, 2023 results: revenue $192.5 million, net income $14.8 million, EPS $0.49. Guidance reaffirmed.

Period: the quarter and year ended December 31, 2023
Revenue: $192.5 million
Net income: $14.8 million
EPS: $0.49
Guidance: reaffirmed
Result: reported results

Exact text from the filing

sleep apnea, today reported financial results for the quarter and year ended December 31, 2023. Recent Business Highlights and Full Year 2024 Guidance • Generated revenue of $192.5 million in the fourth quarter of 2023, a 40% increase over the same quarter last year, and revenue of $624.8 million in full year 2023, a 53% increase over full year 2022 • Achieved

View on SEC.gov

Browse all earnings releases →

Inspire Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001609550-24-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.